Uwe Siebert
#145,970
Most Influential Person Now
Researcher
Uwe Siebert's AcademicInfluence.com Rankings
Uwe Siebertcomputer-science Degrees
Computer Science
#7318
World Rank
#7708
Historical Rank
Machine Learning
#2661
World Rank
#2696
Historical Rank
Artificial Intelligence
#2957
World Rank
#3002
Historical Rank
Database
#4376
World Rank
#4550
Historical Rank
Download Badge
Computer Science
Uwe Siebert's Degrees
- Bachelors Computer Science University of Hamburg
Similar Degrees You Can Earn
Why Is Uwe Siebert Influential?
(Suggest an Edit or Addition)Uwe Siebert's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. (2009) (2821)
- Fractional flow reserve versus angiography for guiding percutaneous coronary intervention in patients with multivessel coronary artery disease: 2-year follow-up of the FAME (Fractional Flow Reserve Versus Angiography for Multivessel Evaluation) study. (2010) (1043)
- Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. (2020) (821)
- Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1. (2012) (731)
- Review Paper: The Effect of Electronic Prescribing on Medication Errors and Adverse Drug Events: A Systematic Review (2008) (641)
- Prevalence and incidence of Parkinson's disease in Europe (2005) (608)
- State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3. (2012) (573)
- Key principles for the improved conduct of health technology assessments for resource allocation decisions (2008) (415)
- Economic Evaluation of Fractional Flow Reserve–Guided Percutaneous Coronary Intervention in Patients With Multivessel Disease (2010) (358)
- Coronary Pressure Measurement After Stenting Predicts Adverse Events at Follow-Up: A Multicenter Registry (2002) (301)
- Good research practices for comparative effectiveness research: approaches to mitigate bias and confounding in the design of nonrandomized studies of treatment effects using secondary data sources: the International Society for Pharmacoeconomics and Outcomes Research Good Research Practices for Retr (2009) (277)
- Good research practices for comparative effectiveness research: analytic methods to improve causal inference from nonrandomized studies of treatment effects using secondary data sources: the ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report--Part III. (2009) (272)
- Long-Term Outcome After Stroke: Evaluating Health-Related Quality of Life Using Utility Measurements (2006) (255)
- Economic burden of stroke: a systematic review on post-stroke care (2016) (252)
- HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality (2009) (249)
- Resistance Training in the Treatment of the Metabolic Syndrome (2010) (244)
- Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry (2010) (212)
- Mercury as a serious health hazard for children in gold mining areas. (2008) (203)
- Modeling Good Research Practices—Overview (2012) (199)
- Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C (2003) (197)
- Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis (2004) (196)
- Long-Term Outcome After Stroke Evaluating Health-Related Quality of Life Using Utility Measurement (2006) (195)
- Cardiac magnetic resonance perfusion imaging for the functional assessment of coronary artery disease: a comparison with coronary angiography and fractional flow reserve. (2006) (184)
- Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound. (1999) (175)
- A systematic meta-analysis of the efficacy and heterogeneity of disease management programs in congestive heart failure. (2006) (172)
- A systematic review on diagnostic accuracy of CT-based detection of significant coronary artery disease. (2008) (170)
- Rate of clinical progression in Parkinson's disease. A prospective study (2007) (159)
- EBM, HTA, and CER: clearing the confusion. (2010) (156)
- When should decision-analytic modeling be used in the economic evaluation of health care? (2003) (156)
- Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. (2011) (152)
- Health-related quality of life in patients with narcolepsy. (2007) (136)
- Challenges in the development and reimbursement of personalized medicine-payer and manufacturer perspectives and implications for health economics and outcomes research: a report of the ISPOR personalized medicine special interest group. (2012) (134)
- Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma (2003) (132)
- Health assessment of artisanal gold miners in Indonesia. (2010) (127)
- Impact of social support, cynical hostility and anger expression on progression of coronary atherosclerosis. (2000) (127)
- Predicted effects of treatment for HCV infection vary among European countries. (2012) (126)
- Cost of illness and its predictors for Parkinson’s disease in Germany (2012) (123)
- Diagnostic performance of stress perfusion and delayed-enhancement MR imaging in patients with coronary artery disease. (2006) (122)
- Long-Term Patency of Internal Mammary Artery Bypass Grafts: Relationship With Preoperative Severity of the Native Coronary Artery Stenosis (2004) (117)
- Effect of Vitamin D Supplementation, Omega-3 Fatty Acid Supplementation, or a Strength-Training Exercise Program on Clinical Outcomes in Older Adults: The DO-HEALTH Randomized Clinical Trial. (2020) (117)
- Evidence for lower variability of coronary artery calcium mineral mass measurements by multi-detector computed tomography in a community-based cohort--consequences for progression studies. (2006) (117)
- Cost effectiveness of peginterferon alpha-2b plus ribavirin versus interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C. (2003) (111)
- Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? (2004) (111)
- The efficiency frontier approach to economic evaluation of health-care interventions. (2010) (108)
- Utility estimates for decision-analytic modeling in chronic heart failure--health states based on New York Heart Association classes and number of rehospitalizations. (2009) (104)
- Epigenome-based cancer risk prediction: rationale, opportunities and challenges (2018) (104)
- Epidemiology of status epilepticus in adults: A population‐based study on incidence, causes, and outcomes (2018) (103)
- Resistance training, visceral obesity and inflammatory response: a review of the evidence (2012) (103)
- Rationale and design of the Fractional Flow Reserve versus Angiography for Multivessel Evaluation (FAME) study. (2007) (101)
- Impact of intravascular ultrasound‐guided stenting on long‐term clinical outcome: A meta‐analysis of available studies comparing intravascular ultrasound‐guided and angiographically guided stenting (2003) (99)
- State-Transition Modeling (2012) (99)
- Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community (2015) (95)
- Assessing the Costs and Cost-Effectiveness of Genomic Sequencing (2015) (95)
- Critical limb ischemia: hybrid MR angiography compared with DSA. (2005) (95)
- Health assessment of artisanal gold miners in Tanzania. (2010) (94)
- Costs of illness and care in Parkinson's Disease: An evaluation in six countries (2011) (92)
- Market uptake of new antiviral drugs for the treatment of hepatitis C. (2008) (91)
- Re-evaluation of the penicillamine challenge test in the diagnosis of Wilson's disease in children. (2007) (91)
- The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol1 (2002) (89)
- Cost-effectiveness of using N-terminal pro-brain natriuretic peptide to guide the diagnostic assessment and management of dyspneic patients in the emergency department. (2006) (89)
- Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics. (2004) (89)
- Cost‐effectiveness of deep brain stimulation in patients with Parkinson's disease (2013) (87)
- Decision-Analytic Modeling to Evaluate Benefits and Harms of Medical Tests: Uses and Limitations (2009) (87)
- The cost-effectiveness of testing for hepatitis C in former injecting drug users. (2006) (86)
- Systematic overview of cost-effectiveness thresholds in ten countries across four continents. (2015) (85)
- Mercury in breast milk - a health hazard for infants in gold mining areas? (2008) (83)
- Progression-free survival as a surrogate endpoint in advanced breast cancer (2008) (83)
- BiomarCaRE: rationale and design of the European BiomarCaRE project including 300,000 participants from 13 European countries (2014) (82)
- Cost-effectiveness analysis in the assessment of diagnostic imaging technologies. (2005) (81)
- Resource utilization and costs of stroke unit care in Germany. (2004) (80)
- Cost of Parkinson's disease in Europe (2005) (73)
- Effects of multiple interventions (2004) (73)
- The socioeconomic impact of narcolepsy. (2004) (73)
- Demonstration of the healthy worker survivor effect in a cohort of workers in the construction industry (2001) (73)
- Quarantine alone or in combination with other public health measures to control COVID‐19: a rapid review (2020) (72)
- The German cervical cancer screening model: development and validation of a decision-analytic model for cervical cancer screening in Germany. (2006) (71)
- Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA. (2019) (70)
- Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. (1999) (70)
- Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection. (2009) (66)
- Gender differences in the association between grip strength and mortality in older adults: results from the KORA-age study (2016) (65)
- Safety of bevacizumab in patients with advanced cancer: a meta-analysis of randomized controlled trials. (2010) (64)
- Are Key Principles for improved health technology assessment supported and used by health technology assessment organizations? (2010) (64)
- A preliminary study on health effects in villagers exposed to mercury in a small-scale artisanal gold mining area in Indonesia. (2016) (62)
- Concepts of ‘Personalization’ in Personalized Medicine: Implications for Economic Evaluation (2014) (60)
- Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria. (2009) (59)
- Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. (2002) (59)
- High-resolution MR imaging of human atherosclerotic femoral arteries in vivo: validation with intravascular ultrasound. (2003) (58)
- Cardiac CT in emergency department patients with acute chest pain. (2006) (58)
- Mercury exposure in female artisanal small-scale gold miners (ASGM) in Mongolia: An analysis of human biomonitoring (HBM) data from 2008. (2011) (57)
- Methods, procedures, and contextual characteristics of health technology assessment and health policy decision making: Comparison of health technology assessment agencies in Germany, United Kingdom, France, and Sweden (2009) (56)
- A validated clinical and biochemical score for the diagnosis of acute heart failure: the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Acute Heart Failure Score. (2006) (51)
- Superiority of age and weight as variables in predicting osteoporosis in postmenopausal white women (2003) (51)
- Predictors of Temporary and Permanent Work Disability in Patients With Inflammatory Bowel Disease: Results of the Swiss Inflammatory Bowel Disease Cohort Study (2013) (51)
- Recall Responses to Tetanus and Diphtheria Vaccination Are Frequently Insufficient in Elderly Persons (2013) (47)
- Prostate-specific antigen testing in Tyrol, Austria: prostate cancer mortality reduction was supported by an update with mortality data up to 2008 (2011) (47)
- The burden of chronic mercury intoxication in artisanal small-scale gold mining in Zimbabwe: data availability and preliminary estimates (2014) (46)
- Postoperative troponin-T predicts prolonged intensive care unit length of stay following cardiac surgery* (2004) (46)
- Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients--the IMPROVED multi-centre study. (2005) (44)
- A network against failing hearts--introducing the German "Competence Network Heart Failure". (2010) (43)
- Long‐term effectiveness and cost‐effectiveness of antiviral treatment in hepatitis C (2010) (43)
- Fractional flow reserve for the prediction of cardiac events after coronary stent implantation: results of a multivariate analysis (2005) (42)
- Being Precise About Precision Medicine: What Should Value Frameworks Incorporate to Address Precision Medicine? A Report of the Personalized Precision Medicine Special Interest Group. (2020) (42)
- Cyclosporine versus tacrolimus (FK 506) for prevention of cardiac allograft vasculopathy. (2000) (41)
- Long-term safety of therapy stratification in patients with intermediate coronary lesions based on intracoronary pressure measurements. (2002) (41)
- Human Biomonitoring Data from Mercury Exposed Miners in Six Artisanal Small-Scale Gold Mining Areas in Asia and Africa (2011) (41)
- Cost-effectiveness of primary HPV screening for cervical cancer in Germany--a decision analysis. (2011) (41)
- Intravascular optical coherence tomography: comparison with histopathology in atherosclerotic peripheral artery specimens. (2006) (40)
- Effectiveness and cost-effectiveness of initial combination therapy with interferon/peginterferon plus ribavirin in patients with chronic hepatitis C in Germany: A health technology assessment commissioned by the German Federal Ministry of Health and Social Security (2005) (40)
- Personalized medicine in Europe: not yet personal enough? (2017) (37)
- Signs and symptoms of mercury-exposed gold miners. (2017) (37)
- Decision-Analytic Models to Simulate Health Outcomes and Costs in Heart Failure (2011) (36)
- Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis. (2007) (36)
- Economic burden of osteoporotic fractures in Austria (2012) (36)
- Comparing the clinical effectiveness of different new-born hearing screening strategies. A decision analysis (2005) (35)
- Cost‐effectiveness of neurostimulation in Parkinson's disease with early motor complications (2016) (35)
- Dopamine transporter imaging and SPECT in diagnostic work‐up of Parkinson's disease: A decision‐analytic approach (2003) (35)
- CAN WE RELIABLY BENCHMARK HEALTH TECHNOLOGY ASSESSMENT ORGANIZATIONS? (2012) (35)
- Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt. (2014) (35)
- Case finding for hepatitis C in primary care: a cost utility analysis. (2006) (34)
- Effects of resistance training on respiratory function in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis (2013) (34)
- Vision and challenges of Evidence-Based Health Informatics: A case study of a CPOE meta-analysis (2010) (34)
- A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives. (2010) (34)
- C-reactive protein levels and post-ICU mortality in nonsurgical intensive care patients. (2010) (33)
- Comparison of pressure measurement, dobutamine contrast stress echocardiography and SPECT for the evaluation of intermediate coronary stenoses. The COMPRESS trial (2004) (33)
- Cost Effectiveness Analysis of Routine Use of Genotypic Antiretroviral Resistance Testing after Failure of Antiretroviral Treatment for HIV (2004) (32)
- Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients — The IMPROVED multi-centre study (2004) (32)
- The Impact of Generic Substitution on Health and Economic Outcomes: A Systematic Review (2015) (31)
- Decision‐analytic evaluation of the clinical effectiveness and cost‐effectiveness of management programmes in chronic heart failure (2008) (31)
- Predictors for hospitalization and outpatient visits in patients with inflammatory bowel disease: results from the Swiss Inflammatory Bowel Disease Cohort Study (2013) (31)
- Development and evaluation of the Parkinson Psychosis Questionnaire (2005) (31)
- Health technology assessment of medical devices: What is different? An overview of three European projects. (2015) (31)
- TREATMENT SWITCHING: STATISTICAL AND DECISION-MAKING CHALLENGES AND APPROACHES (2016) (30)
- Assessment and characterization of time-related differences in plaque composition by intravascular ultrasound-derived radiofrequency analysis in heart transplant recipients. (2008) (30)
- Epidemiology of status epilepticus in adults: Apples, pears, and oranges — A critical review (2020) (29)
- A Randomized Controlled Trial of Disclosing Genetic Risk Information for Alzheimer’s Disease via Telephone (2017) (29)
- Improving the quality of percutaneous revascularisation in patients with multivessel disease in Australia: cost-effectiveness, public health implications, and budget impact of FFR-guided PCI. (2014) (28)
- Tutorial in medical decision modeling incorporating waiting lines and queues using discrete event simulation. (2010) (28)
- Cost effectiveness of haemophilia treatment: a cross-national assessment. (2003) (27)
- When is enough evidence enough? - Using systematic decision analysis and value-of-information analysis to determine the need for further evidence. (2013) (27)
- Reproducibility of neointima quantification with motorized intravascular ultrasound pullback in stented coronary arteries. (2000) (27)
- Cost effectiveness of haemophilia treatment: a cross-national assessment (2005) (27)
- Development and evaluation of the Parkinson Psychosis Questionnaire A screening-instrument for the early diagnosis of drug-induced psychosis in Parkinson's disease. (2005) (26)
- Ensuring Effective Prevention of Iodine Deficiency Disorders. (2016) (26)
- Active Surveillance Versus Watchful Waiting for Localized Prostate Cancer: A Model to Inform Decisions. (2017) (26)
- Benefit, risks and cost-effectiveness of screening for abdominal aortic aneurysm. (2010) (26)
- Cost-effectiveness of primarily human papillomavirus–based cervical cancer screening in settings with currently established Pap screening: A systematic review commissioned by the German Federal Ministry of Health (2008) (25)
- Evaluation of undetected cases during the COVID-19 epidemic in Austria (2020) (25)
- Systematic assessment of decision models in Parkinson's disease. (2004) (24)
- COMMUNICATING THE PARAMETER UNCERTAINTY IN THE IQWIG EFFICIENCY FRONTIER TO DECISION-MAKERS (2014) (24)
- Prognostic value, clinical effectiveness, and cost-effectiveness of high-sensitivity C-reactive protein as a marker for major cardiac events in asymptomatic individuals: A health technology assessment report (2010) (24)
- The Munich score: a clinical index to predict survival in ambulatory patients with chronic heart failure in the era of new medical therapies. (2004) (23)
- Do women with cancer have better survival as compared to men after adjusting for staging distribution? (2011) (23)
- Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion (2015) (22)
- A bias-adjusted evidence synthesis of RCT and observational data: the case of total hip replacement. (2017) (22)
- Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease (2011) (22)
- Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? (2018) (22)
- Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer. (2010) (22)
- Evolution of angiographic restenosis rate and late lumen loss after intracoronary beta radiation for in-stent restenotic lesions. (2004) (21)
- Targeted COVID-19 Vaccination (TAV-COVID) Considering Limited Vaccination Capacities—An Agent-Based Modeling Evaluation (2021) (21)
- IVUS analysis of the acute and long‐term stent result using motorized pullback: Intraobserver and interobserver variability (1999) (20)
- Cost-effectiveness of the sequential application of tyrosine kinase inhibitors for the treatment of chronic myeloid leukemia (2014) (20)
- Evaluation of Contact-Tracing Policies against the Spread of SARS-CoV-2 in Austria: An Agent-Based Simulation (2020) (20)
- Cost‐effectiveness of mediastinal lymph node staging in non–small cell lung cancer (2017) (20)
- Magnetic resonance angiography in the follow-up of distal lower-extremity bypass surgery: comparison with duplex ultrasound and digital subtraction angiography. (2004) (20)
- Are survival rates for Tyrol published in the Eurocare studies biased? (2009) (19)
- Endovascular optical coherence tomography ex vivo: venous wall anatomy and tissue alterations after endovenous therapy (2007) (19)
- Methodenhandbuch für Health-Technology-Assessment, Version 1.2012 (2012) (19)
- Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs. (2012) (19)
- The validation of fractional flow reserve in patients with coronary multivessel disease: a comparison with SPECT and contrast-enhanced dobutamine stress echocardiography (2005) (19)
- Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 1 with Introduction, Screening and the Pathology of Cervical Dysplasia (2019) (19)
- Principles for planning and conducting comparative effectiveness research. (2012) (19)
- Three-year clinical follow-up after strontium-90/yttrium-90 beta-irradiation for the treatment of in-stent coronary restenosis. (2005) (19)
- Effectiveness and Cost-Effectiveness of Sequential Treatment of Patients with Chronic Myeloid Leukemia in the United States: A Decision Analysis (2015) (19)
- Patient‐reported outcome measures in studies of myelodysplastic syndromes and acute myeloid leukemia: Literature review and landscape analysis (2020) (18)
- Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review (2014) (18)
- Prevention of Cervical Cancer. Guideline of the DGGG and the DKG (S3 Level, AWMF Register Number 015/027OL, December 2017) – Part 2 on Triage, Treatment and Follow-up (2019) (17)
- Decision-analytic modeling studies: An overview for clinicians using multiple myeloma as an example. (2015) (17)
- The Krakow Declaration on Iodine: Tasks and Responsibilities for Prevention Programs Targeting Iodine Deficiency Disorders (2018) (17)
- Mapping the EQ-5D index by UPDRS and PDQ-8 in patients with Parkinson’s disease (2013) (17)
- Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review (2017) (17)
- Decision-analytic modeling to evaluate the long-term effectiveness and cost-effectiveness of HPV-DNA testing in primary cervical cancer screening in Germany (2010) (17)
- Predictors of reduced coronary flow reserve in heart transplant recipients without angiographically significant coronary artery disease. (1999) (17)
- Diagnosis and prediction of the occurrence of acute mountain sickness measuring oxygen saturation—independent of absolute altitude? (2016) (17)
- Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response (2012) (17)
- Cost-effectiveness and cost-utility of a structured collaborative disease management in the Interdisciplinary Network for Heart Failure (INH) study (2015) (17)
- Why should we apply ABM for decision analysis for infectious diseases?—An example for dengue interventions (2019) (16)
- Uncertainty Assessment of Input Parameters for Economic Evaluation: Gauss’s Error Propagation, an Alternative to Established Methods (2010) (16)
- Using competence network collaboration and decision-analytic modeling to assess the cost-effectiveness of interferon α-2b plus ribavirin as initial treatment of chronic hepatitis C in Germany (2005) (16)
- International Validation of Reduced Major Morbidity After Minimally Invasive Distal Pancreatectomy Compared With Open Pancreatectomy (2019) (16)
- Cabergoline versus levodopa monotherapy: A decision analysis (2003) (16)
- Safety of FFR-based treatment strategies: the Munich experience (2002) (15)
- The Long-Term Effectiveness and Cost Effectiveness of Organized versus Opportunistic Screening for Breast Cancer in Austria. (2017) (15)
- How Do We Improve the Impact of Iodine Deficiency Disorders Prevention in Europe and Beyond? (2018) (15)
- Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma (2020) (15)
- Health and environmental training in mercury-contaminated areas (2007) (14)
- Economic evaluation of newborn hearing screening: modelling costs and outcomes (2003) (14)
- Sirolimus-eluting stent implantation and beta-irradiation for the treatment of in-stent restenotic lesions: comparison of underlying mechanisms of acute gain and late loss as assessed by volumetric intravascular ultrasound. (2005) (14)
- [Cost of illness and health service patterns in Morbus Parkinson in Austria]. (2009) (14)
- Breast cancer incidence and mortality in Tyrol/Austria after fifteen years of opportunistic mammography screening (2010) (14)
- Introduction of organised mammography screening in Tyrol: results following first year of complete rollout (2011) (14)
- Effects of Adult Patient Portals on Patient Empowerment and Health-Related Outcomes: A Systematic Review (2019) (13)
- Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective (2012) (13)
- Infants and mothers levels of mercury in breast milk, urine and hair, data from an artisanal and small-scale gold mining area in Kadoma / Zimbabwe. (2020) (13)
- Real-World Use of 3rd Line Therapy for Multiple Myeloma in Austria: An Austrian Myeloma Registry (AMR) Analysis of the Therapeutic Landscape and Clinical Outcomes prior to the Use of Next Generation Myeloma Therapeutics (2016) (13)
- Patient-Reported Urinary Incontinence and Erectile Dysfunction Following Radical Prostatectomy: Results from the European Prostate Centre Innsbruck (2015) (13)
- Cost effectiveness of personalized treatment in women with early breast cancer: the application of OncotypeDX and Adjuvant! Online to guide adjuvant chemotherapy in Austria (2015) (13)
- A randomized comparison of 4 doses of intracoronary adenosine in the assessment of fractional flow reserve (2003) (13)
- [Health economics of chronic infectious diseases: the example of hepatitis C]. (2006) (13)
- Algorithms to identify COPD in health systems with and without access to ICD coding: a systematic review (2019) (13)
- Indirect treatment comparison of bevacizumab + interferon-α-2a vs tyrosine kinase inhibitors in first-line metastatic renal cell carcinoma therapy (2011) (12)
- A systematic review of ethical and legal issues in elder care (2020) (12)
- Sex-Related Differences After a Single Bout of Maximal Eccentric Exercise in Response to Acute Effects: A Systematic Review and Meta-analysis. (2020) (12)
- Intravascular ultrasound radiofrequency analysis of the lesion segment profile in ACS patients (2010) (12)
- IQWiG methods--a response to two critiques. (2010) (12)
- An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System. (2012) (12)
- Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online (2017) (12)
- Comparative effectiveness of buprenorphine-naloxone versus methadone for treatment of opioid use disorder: a population-based observational study protocol in British Columbia, Canada (2020) (12)
- Fractional flow reserve predicts major adverse cardiac events after coronary stent implantation (2002) (12)
- Two-stage estimation to adjust for treatment switching in randomised trials: a simulation study investigating the use of inverse probability weighting instead of re-censoring (2019) (12)
- Determinants of willingness to pay for health services: a systematic review of contingent valuation studies (2022) (11)
- Risk factor levels, risk factor combinations, and residual coronary risk: population-based estimates for secondary prevention patients using statins (2012) (11)
- Improved two-stage estimation to adjust for treatment switching in randomised trials: g-estimation to address time-dependent confounding (2020) (11)
- Time-to-event versus ten-year-absolute-risk in cardiovascular risk prevention – does it make a difference? Results from the Optimizing-Risk-Communication (OptRisk) randomized-controlled trial (2016) (11)
- Comparison of volumetric intravascular ultrasound analysis of acute results and underlying mechanisms from cutting balloon and conventional balloon angioplasty for the treatment of coronary in-stent restenotic lesions. (2002) (11)
- Mediator Effect of Balance Problems on Association Between Grip Strength and Falls in Older Adults: Results From the KORA-Age Study (2018) (11)
- Reduction in advanced breast cancer after introduction of a mammography screening program in Tyrol/Austria. (2017) (11)
- Status epilepticus admissions during the COVID‐19 pandemic in Salzburg—A population‐based study (2020) (10)
- Ten recommendations for assessing the comparative effectiveness of therapeutic medical devices: a targeted review and adaptation. (2017) (10)
- Effectiveness, benefit harm and cost effectiveness of colorectal cancer screening in Austria (2019) (10)
- The role of decision-analytic models in the prevention, diagnosis and treatment of coronary heart disease (2002) (10)
- Recommendations for primary studies evaluating therapeutic medical devices were identified and systematically reported through reviewing existing guidance. (2018) (10)
- Systematic Assessment of Decision-Analytic Models for Chronic Myeloid Leukemia (2014) (10)
- Markov state transition models for the prediction of changes in sleep structure induced by aircraft noise. Abstract N° 1047 (2007) (9)
- Supporting Informed Decisions Pegylated Interferon Combined with Ribavirin for Chronic Hepatitis C Virus Infection: An Economic Evaluation (2007) (9)
- The ONCOTYROL Prostate Cancer Outcome and Policy Model (2014) (9)
- HEPATITIS Cost effectiveness of peginterferon α2 b plus ribavirin versus interferon α2 b plus ribavirin for initial treatment of chronic hepatitis C (2003) (9)
- Markov Processes for the Prediction of Aircraft Noise Effects on Sleep (2010) (9)
- Prognostic value, clinical effectiveness and cost-effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events (2009) (9)
- Benefits and harms of prostate cancer screening – predictions of the ONCOTYROL prostate cancer outcome and policy model (2017) (9)
- USING EXPERT OPINION IN HEALTH TECHNOLOGY ASSESSMENT: A GUIDELINE REVIEW (2016) (9)
- Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach (2018) (9)
- Congenital heart defect repair with ADAPT tissue engineered pericardium scaffold: An early-stage health economic model (2018) (9)
- Introduction of organised mammography screening in tyrol: results of a one-year pilot phase (2011) (9)
- Cost effectiveness of breast cancer screening and prevention: a systematic review with a focus on risk-adapted strategies (2021) (9)
- [Reliability of manual medical examination techniques of the cervical spine. Study of quality assurance in manual diagnosis]. (2000) (9)
- Comparison of acute and long-term results and underlying mechanisms from sirolimus-eluting stent implantation for the treatment of in-stent restenosis and recurrent in-stent restenosis in patients in whom intracoronary radiation failed as assessed by intravascular ultrasound. (2004) (8)
- Applicability of two mobile analysers for mercury in urine in small-scale gold mining areas. (2011) (8)
- Health-related quality of life, work productivity and costs related to patients with inflammatory bowel disease in Austria (2020) (8)
- The German Coronary Artery Disease Risk Screening Model: Development, Validation, and Application of a Decision-Analytic Model for Coronary Artery Disease Prevention with Statins (2009) (8)
- [Intravascular optical coherence tomography: differentiation of atherosclerotic plaques and quantification of vessel dimensions in crural arterial specimens]. (2006) (8)
- Cost-Utility of a Prognostic Test Guiding Adjuvant Chemotherapy Decisions in Early-Stage Non-Small Cell Lung Cancer. (2016) (7)
- Multi-criteria decision analysis for health technology assessment in Canada: insights from an expert panel discussion Rev. Pharmacoecon. Outcomes Res. Early online, 1-7 (2014) (2015) (7)
- [Direct and indirect costs of fractures due to osteoporosis in Austria]. (2012) (7)
- Non-mass Enhancement in Breast MRI: Characterization with BI-RADS Descriptors and ADC Values (2021) (7)
- Using decision-analytic modelling to transfer international evidence from health technology assessment to the context of the German health care system (2005) (7)
- Lessons Learned from a Cross-Model Validation between a Discrete Event Simulation Model and a Cohort State-Transition Model for Personalized Breast Cancer Treatment (2016) (7)
- [Priorities in health care: what can we learn from the "Oregon Health Plan"?]. (2002) (7)
- Antiviral treatment initiation costs in chronic hepatitis C. (2005) (7)
- Development of a novel prognostic score for breast cancer patients using mRNA expression of CHAC1. (2017) (7)
- Re: "Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples with Apples". (2020) (7)
- Economic outcomes of sequences which include monoclonal antibodies against vascular endothelial growth factor and/or epidermal growth factor receptor for the treatment of unresectable metastatic colorectal cancer (2014) (6)
- Application of decision-analytic models in personalized medicine for CML treatment decisions made by payers, providers, and patients. (2012) (6)
- 122 HCV BURDEN IN EUROPE: IMPACT OF NATIONAL TREATMENT PRACTICES ON FUTURE HCV-RELATED MORBIDITY AND MORTALITY THROUGH A MODELING APPROACH (2010) (6)
- Cost-effectiveness of peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C (2002) (6)
- OC-17 HCV burden in Europe: Impact of national treatment practices on future HCV-related morbidity and mortality through a modeling approach (2011) (6)
- Screening of the hearing of newborns - Update (2006) (6)
- A Systematic Review on Cost-effectiveness Studies Evaluating Ovarian Cancer Early Detection and Prevention Strategies (2020) (6)
- Oncotyrol--Center for Personalized Cancer Medicine: Methods and Applications of Health Technology Assessment and Outcomes Research. (2015) (6)
- An indirect comparison of the efficacy of bevacizumab plus carboplatin and paclitaxel versus pemetrexed with cisplatin in patients with advanced or recurrent non-squamous adenocarcinoma non-small cell lung cancer (2011) (6)
- Prevalence and incidence of iron deficiency in European community-dwelling older adults: an observational analysis of the DO-HEALTH trial (2022) (6)
- Individual health services (2011) (5)
- Adult patient access to electronic health records. (2021) (5)
- Budget Impact Analysis of Cancer Screening: A Methodological Review (2019) (5)
- Decision-analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency Disorders and Thyroid Disorders: a Systematic Overview. (2020) (5)
- Benefits and Harms of a Prevention Program for Iodine Deficiency Disorders - Predictions of the Decision-Analytic EUthyroid Model. (2020) (5)
- The socioeconomic impact of narcolepsy. Sleep 27, 1123-8 (2004) (5)
- [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany]. (2007) (5)
- Deterministic sensitivity analysis for first-order Monte Carlo simulations: a technical note. (2009) (5)
- Cost-comparison analysis of a multiplatform tumour profiling service to guide advanced cancer treatment (2019) (5)
- Defining decision thresholds for judgments on health benefits and harms using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks: a protocol for a randomised methodological study (GRADE-THRESHOLD) (2022) (5)
- Response from the authors of “Key principles for the improved conduct of health technology assessments for resource allocation decisions” (2008) (5)
- On the role of data, statistics and decisions in a pandemic (2021) (5)
- Development of a core outcome set for myelodysplastic syndromes – a Delphi study from the EUMDS Registry Group (2020) (5)
- Cost-Effectiveness of Early Detection and Prevention Strategies for Endometrial Cancer—A Systematic Review (2020) (5)
- Guidance for a causal comparative effectiveness analysis using 'big real world' evidence: when to start statin treatment. (2019) (5)
- Antiviral combination therapy with interferon/peginterferon plus ribavirin for patients with chronic hepatitis C in Germany: a health technology assessment commissioned by the German Agency for Health Technology Assessment (2003) (5)
- Assessment of effectiveness and cost-effectiveness of HPV testing in primary screening for cervical (2007) (5)
- Long-Term Public Health Impact of Vaccination Against Cervical Cancer in Germany (2007) (5)
- Consideration of international generic distribution policies on patient outcomes in the United States and Germany. (2014) (4)
- Corrigendum to “Effectiveness of bevacizumab- and pemetrexed-cisplatin treatment for patients with advanced non-squamous non-small cell lung cancer” [Lung Cancer 69S1 (2010) S4–S10] (2010) (4)
- Core set of patient-reported outcomes for myelodysplastic syndromes: an EUMDS Delphi study involving patients and hematologists (2021) (4)
- Orchiectomy versus medical therapy with LH-RH analogues for the treatment of advanced prostatic carcinoma (2006) (4)
- Clinical effectiveness of cancer screening biomarker tests offered as self-pay health service: a systematic review. (2016) (4)
- Presentation and medical management of peripheral arterial disease in general practice: rationale, aims, design and baseline results of the PACE-PAD Study (2009) (4)
- Medical decision analysis for first-line therapy of chronic myeloid leukemia (2014) (4)
- Health state utilities among contemporary prostate cancer patients on active surveillance (2018) (4)
- Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays (2018) (4)
- Current and future Burden of Communicable Diseases in the European Union and EEA/EFTA countries (BCoDE). Methodology protocol (2011) (4)
- Mapping the EQ-5 D index by UPDRS and PDQ-8 in patients with Parkinson ’ s disease (2013) (4)
- Barriers against Prevention Programs for Iodine Deficiency Disorders in Europe - A Delphi Study. (2020) (4)
- Effect of guideline orientation on the outcomes of peripheral arterial disease in primary care (2011) (4)
- Extracorporal hemodialysis with acute or decompensated chronical hepatic failure (2006) (3)
- Cost-effectiveness of testing for CYP2C19 loss-of-function carriers following transient ischemic attack/minor stroke: A Canadian perspective (2022) (3)
- Preference-based quality-of-life values in patients with chronic hepatitis C: Results from the German hepatitis C quality-of-life study (2003) (3)
- P1084 Long-term public health effects of vaccination against cervical cancer in Germany: results from a Markov model (2007) (3)
- Health State Utilities in Individuals with Goiter, Hypothyroidism, Hyperthyroidism and Graves’ Disease as an Example for Thyroid Disorders – A Systematic Review (2017) (3)
- PCN2 COST-EFFECTIVENESS OF NEW CERVICAL CANCER SCREENING TECHNOLOGIES:A GERMAN HEALTH TECHNOLOGY ASSESSMENT AND DECISION-ANALYSIS (2002) (3)
- Discrepancy between morphologic and functional criteria of optimal stent deployment using intravascular ultrasound and pressure derived myocardial fractional flow reserve (2005) (3)
- VV6 TRANSFORMING THE UNIFIED PARKINSON'S DISEASE RATING SCALE INTO A UTILITY SCALE (2003) (3)
- IMPROVING PARAMETER ESTIMATION FOR A DECISION-ANALYTIC MARKOV MODEL TO EVALUATE THE USE OF NOVEL BIOMARKER LED STRATEGIES FOR PREVETION OF CARDIOVASCULAR DISEASE (2015) (3)
- Prostate-Specific Antigen Testing in Tyrol , Austria : Prostate Cancer Mortality Reduction Was Supported by an Update with Mortality Data (2012) (3)
- Accounting for increased non-target-disease-specific mortality in decision-analytic screening models for economic evaluation (2013) (3)
- Comorbidities and COVID-19 hospitalization, ICU admission and hospital mortality in Austria (2022) (3)
- Pharmacogenomics Bias - Systematic distortion of study results by genetic heterogeneity (2008) (3)
- Evaluating the effects of a risk-adapted screening program for familial colorectal cancer in individuals between 25 and 50 years of age: study protocol for the prospective population-based intervention study FARKOR (2020) (3)
- Influence of tumor necrosis factor α in rheumatoid arthritis (2005) (3)
- Decision-Analytic Modeling Studies in Prevention and Treatment of Iodine Deficiency and Thyroid Disorders: A Systematic Overview (2020) (3)
- Viral hepatitis: Cost-effectiveness of direct-acting antivirals for chronic hepatitis C (2013) (3)
- Cardiac CT in Emer- gency Department Patients with Acute (2006) (3)
- Evaluating HTA principles (2010) (3)
- Treatment Patterns and Costs of Unclear and Abnormal Cervical Conditions in Germany (2007) (3)
- Quality of life analysis after stereotactic radiofrequency ablation of liver tumors (2020) (2)
- The economic impact of prevention, monitoring and treatment strategies for iodine deficiency disorders in Germany (2020) (2)
- An iterative algorithm for optimizing COVID-19 vaccination strategies considering unknown supply (2022) (2)
- TREATMENT STRATEGIES FOR ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA: A META-ANALYSIS AND INDIRECT TREATMENT COMPARISON. (2015) (2)
- CN4 HPV-BASED PRIMARY CERVICAL CANCER SCREENING IN GERMANY. COST-EFFECTIVENESS RESULTS FROM A DECISION-ANALYTIC MODELING STUDY (2010) (2)
- Cost-effectiveness analysis of superabsorbent wound dressings in patients with moderate-to-highly exuding leg ulcers in Germany. (2021) (2)
- Decision Analysis on the Cost-Effectiveness of Sequential Treatment Strategies for Patients with Chronic Myeloid Leukemia in the United States. (2014) (2)
- Methods for Health Economic Evaluations of Vaccines - Results from an International Expert-Workshop. (2014) (2)
- Reply: Cabergoline versus levodopa therapy (2004) (2)
- Discrepancy between morphologic and functional criteria of optimal stent deployment using intravascular ultrasound and pressure derived myocardial fractional flow reserve. (2002) (2)
- The anemia-independent impact of myelodysplastic syndromes on health-related quality of life (2021) (2)
- [Evidence-based recommendations for the revision of the Austrian periodic health examination]. (2019) (2)
- Diagnostic and Prognostic Value of Serial Dobutamine Stress Echocardiography for Noninvasive Assessment of Cardiac Allograft Vasculopathy (1999) (2)
- HT1 A SYSTEMATIC FRAMEWORK FOR COMPARING METHODS, PROCEDURES, AND IMPACT ACROSS HTA AGENCIES (2008) (2)
- Alternative Conversion Methods for Transition Probabilities in State-Transition Models: Validity and Impact on Comparative Effectiveness and Cost-Effectiveness (2019) (2)
- Effectiveness and Cost-Effectiveness of Triple Therapy with Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from the Brazilian Public Health System Perspective. (2019) (2)
- [Prognostic value and clinical effectiveness of high sensitivity C-reactive protein as a marker in primary prevention of major cardiac events]. (2009) (2)
- Decision-analytic models for breast cancer: Do currently published models meet the requirements of personalized medicine? (2008) (2)
- Impact of barotrauma on acute and late angiographic and clinical outcomes following angioplasty and beta-irradiation of coronary in-stent restenotic lesions. (2004) (2)
- Coronary plaque dimensions and composition by intravascular ultrasound radio frequency lesion segment analysis in stable and unstable angina patients (2009) (2)
- MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer Treatment (2012) (2)
- 885 IMMEDIATE vs. DELAYED TREATMENT IN GENOTYPE 4-HCV INFECTED PATIENTS IN A LIMITED RESOURCES COUNTRY: A COST-EFFECTIVENESS ANALYSIS IN EGYPT (ANRS 12215) (2013) (2)
- Effects of vitamin D, omega-3 fatty acids and a simple home strength exercise program on fall prevention: the DO-HEALTH randomized clinical trial. (2022) (2)
- Economic Evaluation of an N-terminal pro B-type Natriuretic Peptide-supported Diagnostic Strategy among Dyspneic Patients Suspected of Acute Heart Failure in the Emergency Department. (2021) (2)
- Measurement of fractional flow reserve to guide decisions for percutaneous coronary intervention (2008) (2)
- EE1 USING IQWIG'S EFFICIENCY FRONTIER APPROACH FOR THE ECONOMIC EVALUATION OF HEAPTITIS C TREATMENT—A PILOT AND FEASIBILITY STUDY COMMISSIONED BY IQWIG (2009) (2)
- Costs of sequential multiple myeloma treatment for elderly transplant-ineligible patients in the Serbian health care system (2019) (2)
- The Optimizing-Risk-Communication (OptRisk) randomized trial – impact of decision-aid-based consultation on adherence and perception of cardiovascular risk (2019) (2)
- A Systematic Review Of Calibration In Population Models (2017) (1)
- The Impact of Generic Substitution on Health Outcomes and Costs: A Systematic Review (2013) (1)
- The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening. (2014) (1)
- Reply to the letter to the editor by J.G. Dórea “Health hazard for infants: Breast-milk mercury or non-breastfeeding? A dilemma for mothers exposed to mercury vapours” (2009) (1)
- The United States Physican Survey to Populate a Decision-Analytic Model for the Treatment of Chronic Myeloid Leukemia (2013) (1)
- Health technology assessment of utilization, practice and ethical issues of self-pay services in the German ambulatory health care setting (2014) (1)
- Additional treatment with mistletoe extracts for patients with breast cancer compared to conventional cancer therapy alone – efficacy and safety, costs and cost-effectiveness, patients and social aspects, and ethical assessment (2022) (1)
- Cost utility of fractional flow reserve-guided percutaneous coronary intervention in multivessel coronary artery disease in Brazil. (2018) (1)
- Chronic Hepatitis C treatment for genotype 2 or 3 in Brazil: cost effectiveness analysis of peginterferon plus ribavirin as first choice treatment (2014) (1)
- New Perspective for Soft Tissue Closure in Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Barbed Sutures (2021) (1)
- Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis. (2014) (1)
- [Linkage of Clinical and Claims Data in the Evaluation of Post-Stroke Care - SeDaStro: Experiences from the Tyrolian StrokeCard Program]. (2020) (1)
- Causal analyses with target trial emulation for real-world evidence removed large self-inflicted biases: Systematic bias assessment of ovarian cancer treatment effectiveness. (2022) (1)
- [Prospective study of the frequency and extent of donor-transmitted coronary disease after heart transplantation by intravascular ultrasound]. (2008) (1)
- The influence of analytic time horizon and treatment management algorithms on the cost of peginterferon alfa-2b plus ribavirin therapy for chronic hepatitis C (2003) (1)
- Safety and mechanisms of intracoronary manual stepping brachytherapy as gained from serial angiographic and intravascular ultrasound studies. (2002) (1)
- Neurodevelopment of Infants in a Mercury Contaminated Crea in Zimbabwe (2013) (1)
- Comparative Effectiveness of Treatment Strategies For Multiple Myeloma in Elderly Patients: A Network Meta-Analysis (2016) (1)
- Estimation of Input Costs for a Markov Model in a German Health Economic Evaluation of Newer Antidepressants (2018) (1)
- Effects of Motorcycle Noise on Annoyance—A Cross-Sectional Study in the Alps (2020) (1)
- Messung der fraktionierten Flussreserve zur Indikationsstellung der perkutanen Koronarintervention Measurement of fractional flow reserve to guide decisions for percutaneous coronary intervention (2008) (1)
- [Parameter of evidence-based medicine in health care economics]. (1999) (1)
- Effectiveness and cost-effectiveness of initial antiviral treatment in patients with chronic hepatitis C. A German health technology assessment and decision analysis commissioned by the German Federal Ministry of Health (2003) (1)
- PMD40 Cost Effectiveness of Fractional Flow reserve Measurement in Multivessel Coronary Artery Disease in Belgium and France (2011) (1)
- PCN43 NEW CERVICAL CANCER SCREENING POLICY IN GERMANY - WHAT IS THE IMPACT ON THE BENEFIT-HARM BALANCE? (2019) (1)
- Long-Term Effectiveness and Cost Effectiveness of Multiple Myeloma Treatment Strategies for Elderly Transplant-Ineligible Patients in Serbia (2020) (1)
- Upstream Statin Therapy and Long-Term Recurrence of Atrial Fibrillation after Cardioversion: A Propensity-Matched Analysis (2021) (1)
- [Clinical and economic aspects of chronic coronary restenosis: potential advantage of intracoronary brachytherapy]. (2001) (1)
- The Use Of Administrative Data To Determine Prevalence And Incidence Of Copd: A Systematic Review (2016) (1)
- The Socioeconomic Impact of Narcolepsy NARCOLEPSY (2004) (1)
- PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model (2012) (1)
- Impact of the Age of Vaccination Against Cervical Cancer on Long-Term Public Health and Economic Effects in Germany: Results from a Markov Model (2007) (1)
- The Effectiveness of Quarantine alone or in Combination with Other Public Health Measures to Control Coronavirus Disease 2019: a Rapid Review (2020) (1)
- for Multivessel Evaluation) Study 2-Year Follow-Up of the FAME (Fractional Flow Reserve Versus Angiography Coronary Intervention in Patients With Multivessel Coronary Artery Disease: Fractional Flow Reserve Versus Angiography for Guiding Percutaneous (2010) (1)
- 58PEVALUATION OF BREAST CANCER TEST-TREATMENT STRATEGIES USING DECISION-ANALYTIC MODELING – PRELIMINARY RESULTS FOR THE 21-GENE ASSAY RECURRENCE SCORE (2013) (1)
- PNL10 THE SOCIOECONOMIC IMPACT OF NARCOLEPSY (2004) (1)
- Modelling chronic malnutrition in Zambia: A Bayesian distributional regression approach (2021) (1)
- Php73 Applying Key Principles for Improved Health Technology Assessment: An Analysis of 14 Hta Organizations (2009) (1)
- Results of an International Expert Task Force on a Health Technology Assessment Framework for Personalized Medicine in Cancer (2015) (1)
- Framework for Evidence Assessment Based on Grade and Application to HPV Vaccination in Males in the European Health Care Context (2013) (1)
- PIN19 A COST-EFFECTIVENESS ANALYSIS OF A PROPHYLACTIC CERVICAL CANCERVACCINE IN GERMANY: RESULTS FROM A HEALTH ECONOMIC MODEL (2007) (1)
- ISPOR-SMDM task force's recommendations for good modeling practices-reply to letter to the editor by Corro Ramos. (2013) (1)
- Struktur und Inhalt der German Hepatitis C Economic Database: Ein Instrument der German Hepatitis C Model Group (GEHMO).: GMDS-Jahrestagung 2003. (2003) (1)
- PCV46 Screening for Familial Hypercholesterolemia - a Systematic Review on Evidence of Effective and Cost-Effective Screening Strategies Identified By Decision-Analytic Modeling Studies (2020) (0)
- Uncertainty and Cost-Effectiveness Analysis of the Sequential Application of Tyrosine Kinase Inhibitors for the Treatment of Chronic Myeloid Leukemia (2013) (0)
- MERCURY USE IN ARTISANAL SMALL-SCALE GOLD MINING IN ZIMBABWE: DISABILTY-ADJUSTED LIFE YEARS (DALYS) OF CHRONIC MERCURY INTOXICATION (2011) (0)
- 1157-44 Are high doses of intracoronary adenosine an alternative to standard intravenous adenosine for the assessment of fractional flow reserve? (2004) (0)
- Minimally invasive distal pancreatectomy reduces major morbidity and length of stay compared to the open approach: an international validation (2020) (0)
- Prevalence of Mycoplasma genitalium infection among HIV PrEP users: a systematic review and meta-analysis (2023) (0)
- Decision-analytic modeling for early health technology assessment of medical devices – a scoping review (2022) (0)
- Prostate-Specific Antigen Testing in Tyrol , Austria : Prostate Cancer Mortality Reduction (2012) (0)
- PMD10 Impact Analyses of Fractional Flow Reserve-Guided Percutaneous Coronary Intervention in Patients with Multivessel Disease in France and Belgium (2011) (0)
- POSA172 How to Optimize COVID-19 Vaccination Considering Limited Vaccination Capacities: A Decision-Analytic Framework and Modeling Study (2022) (0)
- PMD83 - CERVICAL CANCER SCREENING IN EUROPE - A SYSTEMATIC REVIEW ON COST EFFECTIVENESS STUDIES WITH SPECIFIC INTEREST ON RISK-ADAPTED STRATEGIES (2018) (0)
- SYSTEMATIC OVERVIEW OF RESPONSE CRITERIA AMONG PATIENTS WITH MYELODYSPLASTIC SYNDROMES (2016) (0)
- PCR232 The Use of EuroQol EQ-5D in the Middle East and North Africa Region: A Systematic Review (2022) (0)
- Comparison of endovascular infrapopliteal revascularization strategies based on the angiosome model in diabetic patients within critical limb ischemia (2020) (0)
- Assessing Type and Impact of Biases Potentially Occurring when Analyzing Real World Evidence: The Case of Second Line Treatment for Ovarian Cancer (2018) (0)
- Predicting aircraft noise induced changes in sleep structure with Markov models (2008) (0)
- Guidance for Developing A Study Protocol of A Causal Comparative Effectiveness Analysis in “Big Data”: The Case of When To Start Statin Treatment (2017) (0)
- Outcomes of medical management of peripheral arterial disease in general practice: follow-up results of the PACE-PAD Study (2010) (0)
- 1456 Coronary pressure-based fractional flow reserve in patients with coronary stenosis. A decision analysis (2003) (0)
- PCN9 From Indirect Evidence to Direct Evidence: A Real-World Example for the Value of Indirect Treatment Comparisons in Second-Line NSCLC Therapy (2012) (0)
- PCN22 A SYSTEMATIC EVALUATION OF THE IMPACT OF THE SCREENING INTERVAL ON EFFECTIVENESS AND COST-EFFECTIVENESS OF DIFFERENT CERVICAL CANCER SCREENING TECHNIQUES (2004) (0)
- Guidance on the use of complex systems models for economic evaluations of public health interventions. (2023) (0)
- PNL24 COMPARING CLASSIFICATION AND REGRESSION TREE ANALYSIS WITH MULTIPLE REGRESSION FOR TRANSLATING A CLINICAL PARKINSON'S DISEASE SCALE INTO UTILITIES (2004) (0)
- Health-Economic Evaluation of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Treatment of Chronic Genotype 1 Hcv Infection in Germany (2016) (0)
- Multiple Myeloma and Health-Related Quality of Life from EQ-5D and EORTC: A Systematic Literature Review (2016) (0)
- Methodological features of prostate cancer screening models – A review of simulation modelsDragan Gogov (2016) (0)
- Does health-related quality of life reflect disease severity in chronic hepatitis C patients? (2002) (0)
- PRM61 External Validation of a Cardio-Vascular Disease Model (2012) (0)
- DNA methylation-based detection and prediction of cervical intraepithelial neoplasia grade 3 and invasive cervical cancer with the WID™-qCIN test (2022) (0)
- PNL22 EFFECT OF DISEASE-SPECIFIC COMPLICATIONS ON THE PREDICTION OF UTILITIES IN PARKINSON'S DISEASE (2004) (0)
- Contents Vol. 94, 2015 (2015) (0)
- MERCURY EXPOSURE OF BREAST FED INFANTS IN A SMALL SCALE GOLD MINING AREA IN ZIMBABWE (2011) (0)
- PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four Continents (2011) (0)
- [Clinical experiences with Lamuran in chronic arterious circulatory disorders and in a case of femoral embolism]. (1972) (0)
- HP2 THE IMPACT OF TREATMENT MANAGEMENT ALGORITHMS AND EVALUATED TIME HORIZON ON ANTIVIRAL TREATMENT COSTS IN CHRONIC HEPATITIS C (2003) (0)
- Authors’ response: on the role of data, statistics and decisions in a pandemic (2022) (0)
- PMS23 BURDEN OF ILLNESS OF OSTEOPOROSIS IN AUSTRIA (2010) (0)
- PRM21 Communicating to Decision Makers the Parameter Uncertainty in the IQWiG Efficiency Frontier Approach (2012) (0)
- The Effects of Four Weeks Treatment with Different Doses of the Pesticide Dimethoate and / or Arsenic on the Chromosomes of Young Rats (1999) (0)
- PCV34 COST-EFFECTIVENESS OF FRACTIONAL FLOW RESERVE TESTING TO GUIDE PERCUTANEOUS CORONARY INTERVENTION IN THE DRUG-ELUTING STENT ERA: A DECISION ANALYSIS (2003) (0)
- The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany (2013) (0)
- PP98 Occupational Therapy For Adult Persons With Cognitive Impairments: A Systematic Overview On Clinical Efficacy (2022) (0)
- ' s response to reviews Title : HCV-Related Burden of Disease in Europe : A Systematic Assessment of Incidence , Prevalence , Morbidity , and Mortality (2008) (0)
- [Diagnostic criteria and new classification of the cervical spine syndrome]. (2000) (0)
- PCV47 DECISION ANALYSIS ON EFFECTIVENESS AND COST-EFFECTIVENESS OF DISEASE MANAGEMENT PROGRAMS FOR THE TREATMENT OF HEART FAILURE (2004) (0)
- Fractional flow reserve predicts major adverse cardiac events after coronary stent (2002) (0)
- PCN55 Budget IMPACT of Implementing HPV Testing in Cervical Cancer Screening in Austria - a MODEL Based Analysis (2020) (0)
- PCN38 THE IMPACT OF SCREENING ADHERENCE ON MEDICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF CERVICAL CANCER SCREENING IN GERMANY—A DECISION ANALYSIS (2004) (0)
- V35 The cost-effectiveness of deep brain stimulation for Parkinson's disease (2011) (0)
- Raising the standards of patient‐centered outcomes research in myelodysplastic syndromes: Clinical utility and validation of the subscales of the QUALMS from the MDS‐RIGHT project (2022) (0)
- MODELING APPROACHES FOR ANALYSING HEALTH CARE PROBLEMS – AN INTRODUCTORY OVERVIEW AND COMPARISON (2012) (0)
- 2022-RA-670-ESGO Age limits of mammography screening – a decision-analytic evaluation of the benefit-harm balance to inform decision making for the German screening context (2022) (0)
- EE406 Colorectal Cancer Screening - Benefit-Harm and Cost-Effectiveness Analysis of Population-Wide Screening Strategies in Austria (2022) (0)
- PIN6 CLINICAL EFFECTIVENESS AND COST-EFFECTIVENESS OF ANTIVIRAL COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B AND RIBAVIRIN FOR CHRONIC HEPATITIS C ADMINISTERED ACCORDING TO THE NEW GENOTYPESPECIFIC GUIDELINES (2004) (0)
- Systematic Overview On Value-Of Information Analyses In Cancer Research. (2014) (0)
- EE131 Health-Economic Evaluation of Early Screening for Individuals Younger Than Age 50 with Familial Colorectal Cancer Risk Based on a Decision Analysis within the Farkor Study (2022) (0)
- PCN109 Quality of Life Assessment of Chronic Myeloid Leukemia Patients in Austria: Cross-Sectional Pilot Study Using the EQ-5D (2012) (0)
- PCN4I ASSESSMENT OF DIFFERENT STRATEGIES FOR DETERMINING DIAGNOSIS AND RESECTABILITY IN PATIENTS WITH SUSPECTED PANCREATIC CANCER (2004) (0)
- PCV66 POOLED EFFICACY OF DISEASE MANAGEMENT PROGRAMS IN PATIENTS WITH CONGESTIVE HEART FAILURE—A SYSTEMATIC REVIEW (2004) (0)
- Cost-Effectiveness of Using a Prognostic Test to Guide Treatment Decisions in Early Stage Non-Small Cell Lung Cancer (NSCLC) (2014) (0)
- O0025 The social cost of narcolepsy (2007) (0)
- PMD84 - COST EFFECTIVENESS OF ENDOMETRIAL CANCER SCREENING AND PREVENTION - A SYSTEMATIC REVIEW OF ECONOMIC MODELS (2018) (0)
- PMC11 COMPARING DIFFERENT APPROXIMATION METHODS FOR REMAINING LIFE EXPECTANCY IN DECISION TREES (2004) (0)
- P16 COVID-19 Vaccination Strategies Considering a Vaccine Adapted to a New Variant of Concern: A Decision-Analytic Modeling Study (2022) (0)
- Clinical benefit and cost-effectiveness of antiviral therapy in treatment-naive patients with chronic hepatitis C. A german health technology assessment commissioned by the German Federal Ministry of Health (2015) (0)
- Markov State Transition Models for the Prediction of Noise-InducedSleep Disturbances (2006) (0)
- Evaluation of Effectiveness, Benefit Harm and Cost Effectiveness of Colonoscopy and Occult Blood Tests for an Organized Population-based Colorectal Cancer Screening in Austria (2019) (0)
- Covariate-adjusted analysis of the Phase 3 REFLECT study of lenvatinib versus sorafenib in the treatment of unresectable hepatocellular carcinoma (2020) (0)
- PCN446 A CASE STUDY OF BREAST CANCER TREATMENT DEMONSTRATING THE IMPACT OF TIME DEPENDENT TRANSITION PROBABILITY ADJUSTMENTS ON COMPARATIVE COST EFFECTIVENESS (2019) (0)
- PMD77 - ECONOMIC EVALUATION OF SCREENING AND PREVENTION STRATEGIES FOR OVARIAN CANCER: A SYSTEMATIC REVIEW (2018) (0)
- Overview on Epidemiological Data For Multiple Myeloma In Austria (2016) (0)
- 20-Year Public Health Predictions for Chronic Hepatitis C-Related Morbidity and Mortality–A GEHMO Simulation (2004) (0)
- Review Article A Systematic Meta-Analysis of the Efficacy and Heterogeneity of Disease Management Programs in Congestive Heart Failure (2006) (0)
- Estimating Crossover Bias In A Randomized Clinical Trial Of Ovarian Cancer Treatment. (2014) (0)
- Predictors for resource consumption in patients with ulcerative colitis disease. Results from the analysis of a nationwide inflammatory bowel disease cohort. (2010) (0)
- PCV4 META-ANALYSIS OF THE DIAGNOSTIC ACCURACY OF PRESSURE MEASUREMENTS IN CORONARY ARTERY DISEASE (2006) (0)
- Evaluation of a targeted COVID‐19 vaccination strategy for Austria–a decision-analytic modeling study (2021) (0)
- PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained Resources (2011) (0)
- PGI17 ARTIFICIAL LIVER SUPPORT SYSTEMS—A MEDICAL AND HEALTH ECONOMIC HTA-REPORT (2005) (0)
- Market uptake of pegylated interferons for the treatment of hepatitis C in Europe : meeting abstract (2008) (0)
- Abstracts from the European Society for Medical Decision Making Meeting Rotterdam, the Netherlands, June 7-8, 2004 (2004) (0)
- PHL10 ASSESSING PATIENT PREFERENCES AND QUALITY-ADJUSTED LIFE YEARS (QALY) OF PROPHYLACTIC HAEMOPHILIA TREATMENT (2003) (0)
- PIN90 Towards Best Practices for Handling Uncertainties in Health Technology Assessments for HPV Vaccination to Better Inform Decision Making (2012) (0)
- MC7 THE PHARMACOGENOMICS BIAS IN DECISION MODELS (2005) (0)
- PRACTICES FOR DESIGNING NON-RANDOMIZED STUDIES OF TREATMENT EFFECTS USING SECONDARY DATABASES : Report of the ISPOR Retrospective Database Analysis Task Force – Part II (2009) (0)
- Overview on Cost-Effectiveness Results of Decision-Analytic Studies for the Treatment of Multiple Myeloma (2013) (0)
- Fractional flow reserve measurement after coronary stenting in patients with hypertension and diabetes: Insights from a large multicenter registry (2003) (0)
- Population Models Suppporting Decision Making on a Policy Level – A Systematic Review (2018) (0)
- PCN70 MODELLING THE COST EFFECTIVENESS OF FIRST-LINE COMBINATION TREATMENT WITH BEVACIZUMAB PLUS IRINOTECAN AND INFUSIONAL FLUOROPYRIMIDINES VERSUS IRINOTECAN AND INFUSIONAL FLUOROPYRIMIDINES IN METASTATIC COLORECTAL CANCER PATIENTS IN SWEDEN (2009) (0)
- CO4 How Can the Long-Term Benefits and Harms of Screening Be Transparently Quantified and Contrasted for Informed Decision-Making? Colorectal Cancer Screening for Persons at Familial Risk (FARKOR) (2022) (0)
- [Case of Reiter's disease in chronic bilateral maxillary sinusitis]. (1958) (0)
- Familial hypercholesterolemia: A systematic review of modeling studies on screening interventions. (2022) (0)
- PHP159 Structures for the Role of Health Technology Assessment in Translational Research (2011) (0)
- Reducing overtreatment associated with overdiagnosis in cervical cancer screening—A model‐based benefit–harm analysis for Austria (2020) (0)
- Estimating Treatment-Switching Bias in a Randomized Clinical Trial of Ovarian Cancer Treatment: Combining Causal Inference with Decision-Analytic Modeling (2021) (0)
- The meaning of muscularity for successful aging (2017) (0)
- German initiative for specialized training programs in epidemiology (2000) (0)
- Markov Model Calibration of Weibull Distributed Transition Probabilities Using Scientific Python Optimization Packages (2018) (0)
- The Application of Population Models to Improve Access to Medical Innovations and Population Health – A Systematic Review (2016) (0)
- UT4 PATIENT-DERIVED UTILITY ESTMATES OF CHRONIC HEPATITIS C BASED ON EQ-5D AND RS SCORES (2002) (0)
- New Reimbursement Schemes for Stratified Medicine in Oncology - A Systematic Review. (2014) (0)
- Overview and Evaluation of Decision-analytic Models for the Treatment of Multiple Myeloma (2013) (0)
- PMU18 ECONOMIC EVALUATION OF AN NT-PROBNP-SUPPORTED DIAGNOSTIC STRATEGY AMONG DYSPNEIC PATIENTS SUSPECTED OF ACUTE HEART FAILURE IN THE EMERGENCY DEPARTMENT (2020) (0)
- Application, feasibility, and efficacy of a combined intravascular ultrasound and stent delivery system: results from a prospective multicenter trial. (2005) (0)
- PCN69 COST-EFFECTIVENESS OF FIRST-LINE COMBINATION TREATMENT WITH BEVACIZUMAB PLUS FOLFIRI VERSUS FOLFIRI IN PATIENTS WITH METASTATIC COLORECTAL CANCER: A UK PERSPECTIVE (2009) (0)
- Do budget impact analyses for screening of cancers follow international guidelines?: A systematic review (2017) (0)
- Abstract 1063: Economic Evaluation of the Fractional Flow Reserve vs. Angiography for Multivessel Evaluation (FAME) Study (2009) (0)
- Towards Improved Cervical Cancer Primary Screening in Austria - A Decision-Analytic Benefit-Harm Analysis (2016) (0)
- MERCURY EXPOSURE DATA FROM GOLD MINERS IN INDONESIA, MONGOLIA, PHILIPPINES, TANZANIA AND ZIMBABWE (2011) (0)
- PIN29 EFFECTIVENESS AND COST-EFFECTIVENESS OF HEPATITIS C SCREENING—A SYSTEMATIC REVIEW (2008) (0)
- PMD31 DECISION-ANALYTIC MODELING IN PARKINSON'S DISEASE (2003) (0)
- PCN163 SEQUENTIAL TREATMENT REGIMENS FOR ELDERLY PATIENTS WITH MULTIPLE MYELOMA: A COST-EFFECTIVENESS ANALYSIS INCLUDING EXPERIENCE FROM REAL-WORLD DATA (2019) (0)
- 53: How Often Do Emergency Department Patients with Chest Pain Meet Eligibility Criteria for Multi-Detector Computerized Tomography of the Coronary Arteries? (2006) (0)
- Uwe Siebert secondary prevention patients using statins Risk factor levels , risk factor combinations , and residual coronary risk : population-based estimates for (2012) (0)
- P116 FIRST APPLICATION OF RISK ADVANCEMENT PERIODS TO LIPID RATIOS (2010) (0)
- Deriving Core Patient-Reported Outcomes in Patients with Myelodysplastic Syndromes — a Delphi Survey from the European-MDS Registry (2018) (0)
- PCN63 META-ANALYTIC, TRIAL-LEVEL APPROACH TO VALIDATION OF PROGRESSION-FREE SURVIVAL AS A SURROGATE ENDPOINT IN ADVANCED BREAST CANCER (2007) (0)
- PNL28 CENTERED REGRESSION FUNCTIONS AS A TECHNIQUE TO IMPROVE FLEXIBILITY AND TRANSFERABILITY OF MARKOV MODELS (2004) (0)
- PCV30 COST-EFFECTIVENESS OF N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE IN THE DIAGNOSTIC ASSESSMENT AND MANAGEMENT OF PATIENTS WITH DYSPNEA IN THE EMERGENCY DEPARTMENT (2004) (0)
- Study Protocol of a Causal Comparative Effectiveness Analysis and Data Availability in the Austrian Setting: The Case of When to Start Statin Treatment for Prevention. Posterpräsentation (2018) (0)
- IN2 Chronic Hepatitis C Treatment For Genotype 2 Or 3: COST-Effectiveness Analysis of Peg as First Line Treatment With the Brazilian Protocol (2011) (0)
- PND17 THE COST-EFFECTIVENESS OF DEEP BRAIN STIMULATION IN PARKINSON'S DISEASE PATIENTS (2009) (0)
- Health Technology Assessment (HTA) and its relevance to cross-border healthcare in Europe (2017) (0)
- 515 Cost-effectiveness of peginterferon plus ribavirin in a real-world population of patients with chronic hepatitis C and associated comorbidities (2004) (0)
- PCN4 Decision-Analytic Model for the First-Line Therapy of Chronic Myeloid Leukemia (2012) (0)
- PCN161 DECISION-ANALYTIC MODELING IN CHRONIC MYELOID LEUKEMIA—A SYSTEMATIC OVERVIEW (2010) (0)
- Population Models Supporting Decicion Making on a Policy Level – A Systematic Review. Posterpräsentation (2017) (0)
- The economic impact of treatment management strategies in antiviral therapy of chronic hepatitis C (2015) (0)
- Personalized prostate cancer screening accounting for individual risk factors and preferences (2016) (0)
- PDB51 PREVENTION AS A PUBLIC HEALTH MEASURE: LONG-TERM EFFECTIVENESS AND COST EFFECTIVENESS OF A POPULATION-BASED IODINE DEFICIENCY DISEASES PREVENTION PROGRAM (2019) (0)
- PCN13 A COMPARATIVE EFFECTIVENESS ASSESSMENT OF FIRST-LINE BEVACIZUMAB + INTERFERON ALPHA-2A VS SUNITINIB IN METASTATIC RENAL CELL CARCINOMA (2009) (0)
- Cost-Effectiveness Of Ombitasvir/Paritaprevir/Ritonavir With Or Without Dasabuvir For The Treatment Of Chronic Hepatitis C Patients Infected With Genotype 1 Or 4 In France (2016) (0)
- PCV76 MEASUREMENT OF FRACTIONAL FLOW RESERVE IN PATIENTS WITH CORONARY ARTERY DISEASE TO GUIDE TREATMENT—RESULTS FROM A HEALTH TECHNOLOGY ASSESSMENT AND DECISION ANALYTIC MODEL (2007) (0)
- PCV73 ATOOL FOR MODELING MORTALITY DIFFERENCES IN PREDICTIVE SCREENING MODELS (2007) (0)
- Effectiveness of Omega-3-Fatty Acids in Psoriasis (2009) (0)
- KL2: Understanding HCV disease progression and the associate cost (2014) (0)
- DALYs in Chronic Hepatitis C : A Paneuropean Perspective (2010) (0)
- Corrigendum to: Cost-effectiveness analysis of human papillomavirus-vaccination programs to prevent cervical cancer in Austria [Vaccine 27 (2009) 5133–5141] (2014) (0)
- Costs of Multiple Myeloma Management And Treatment For Elderly Patients Who Are Not Transplant Candidates In The Serbian Health Care System (2016) (0)
- [Decision-analytic modelling: Aims, strengths and limitations. Editorial] (2006) (0)
- Erratum to: Outcomes of medical management of peripheral arterial disease in general practice: follow-up results of the PACE-PAD Study (2010) (0)
- Determinants of low health-related quality of life in patients with myelodysplastic syndromes: EUMDS registry study. (2023) (0)
- MT4 Study Design Recommendations in ISO Standards for High-Risk Medical Devices: A Systematic Review of the HORIZON2020 Core-MD Project (2022) (0)
- PMD29 A MULTI-OUTCOME DECISION MODEL FOR PARKINSON'S DISEASE (2003) (0)
- Effectiveness and Cost-Effectiveness of Triple Therapy With Telaprevir and Boceprevir for Chronic Hepatitis C: A Decision Analysis from The Perspective of The Brazilian Public Health System (2017) (0)
- PNL21 INDEPENDENT EFFECT OF DYSKINESIA ON HEALTHRELATED QUALITY OF LIFE IN PATIENTS WITH PARKINSON'S DISEASE—A MULTIVARIATE ANALYSIS (2004) (0)
- PMD80 - IS SCREENING FOR OVARIAN CANCER EFFECTIVE AND COST EFFECTIVE IN AUSTRIA? A MODEL-BASED ECONOMIC EVALUATION (2018) (0)
- PCN153 Application of Real World Data to Inform a Breast Cancer Decision - Analytic Model in Austria and the U.S - Preliminary Outcomes of Data Collection (2012) (0)
- To stop or not to stop: a value of information view (2018) (0)
- A prognostic test to guide adjuvant chemotherapy (ACT) decisions in early-stage non-small cell lung cancer (NSCLC): A cost-effectiveness analysis. (2014) (0)
- Development and validation of a Markiv State Transition Model for the prediction of sleep disturbances induced by aircraft noise (2004) (0)
- PCN141 QUALITY OF LIFE (QOL) IN PATIENTS WITH METASTATIC BREAST CANCER (MBC) FROM THE AVADO STUDY: THE IMPORTANCE OF IMPUTATION METHODS FOR HANDLING MISSING DATA (2009) (0)
- Systematic Review of Quality of Life Measurement Instruments and Response Criteria Among Patients with Myelodysplastic Syndromes (2016) (0)
- Cost-Effectiveness Analysis of Combination Therapy with Peginterferon and Ribavirin for Patients with Chronic Hepatitis C and Associated Diseases in the German Health Care Context (2004) (0)
- Optimizing outcomes in heart failure: 2022 and beyond. (2023) (0)
- Causal evidence in health decision making: methodological approaches of causal inference and health decision science (2022) (0)
- PCN14 AN INDIRECT COMPARISON OF THE EFFICACY OF BEVACIZUMAB PLUS CISPLATIN AND GEMCITABINE (BCG) OR BEVACIZUMAB PLUS CARBOPLATIN AND PACLITAXEL (BCP) VERSUS CETUXIMAB PLUS VINORELBINE AND CISPLATIN (CVC) IN PATIENTS WITH ADVANCED OR RECURRENT NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC) (2009) (0)
- Personalized treatment of women with early breast cancer: a risk-group specific cost-effectiveness analysis of adjuvant chemotherapy accounting for companion prognostic tests OncotypeDX and Adjuvant!Online (2017) (0)
- Umbrella review and meta-analysis of reconstructed individual patient data of mortality following conventional endovascular and open surgical repair of infrarenal abdominal aortic aneurysm. (2023) (0)
- Comparative Effectiveness Analysis Using Real World Evidence (RWE) and Applying a Causal Marginal Structural Model: the Case of Second-Line Treatment in Patients with Ovarian Cancer (2018) (0)
- PNL25 INTERNAL, EXTERNAL, AND CROSS-MODEL VALIDATION OF A MULTI-OUTCOME DECISION MODEL FOR PARKINSON'S DISEASE (2004) (0)
- 702 Evaluation of the direct and indirect causal effect of risk factor interventions on coronary heart disease. A WHO project (2003) (0)
- REVIEW ARTICLE Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review (2014) (0)
- PCN248 ESTIMATING THE UNBIASED OS-BENEFIT FOR APALUTAMIDE (APA) VERSUS ANDROGEN DEPRIVATION THERAPY (ADT) IN PATIENTS WITH NON-METASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) FROM SPARTAN, ADJUSTING FOR SUBSEQUENT THERAPY USING RANDOMIZED DATA EXTERNAL TO THE TRIAL (2019) (0)
- SMDM CORE COURSE: INTRODUCTION TO MEDICAL DECISION ANALYSIS (DECISION-ANALYTIC MODELING) (2016) (0)
- PDB45 - COSTS OF PREVENTION, MONITORING AND TREATMENT OF IODINE DEFICIENCY DISORDERS IN GERMANY (2018) (0)
- Cost-Effectiveness of Different Cervical Cancer Primary Screening Using Cytology, HPV Or P16/KI-67 Testing Alone Or in Combinations for The Austrian Health Care Context (2016) (0)
- Advances in Prostate Cancer (2018) (0)
- IN4 POPULATION-BASED EVALUATION OF FUTURE BURDEN OF DISEASE AND COSTS RELATED TO CHRONIC HEPATITIS C AND ANTIVIRAL TREATMENT STRATEGIES (2004) (0)
- PCN42: POOLING CLINICAL AND COST OUTCOMES: A CASE STUDY OF BEST SUPPORTIVE CARE (BSC) IN ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) (2010) (0)
- PATIENT-REPORTED OUTCOME MEASURES IN CLINICAL STUDIES FOR MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOID LEUKEMIA: A LITERATURE REVIEW AND LANDSCAPE ANALYSIS (2019) (0)
- PNL3 PREDICTORS FOR DIRECT AND INDIRECT COSTS IN PARKINSON'S DISEASE (2004) (0)
- THE BENEFIT-HARM FRONTIER OF HPV PRIMARY SCREENING FOR CERVICAL CANCER IN GERMANY: ESTIMATES FROM A SYSTEMATIC DECISION -ANALYSIS (2013) (0)
- CN8 METHODOLOGICAL ISSUES OF CONTROL ARM ADJUSTMENTS FOR COMPARATIVE EFFECTIVENESS ASSESSMENTS: AN EXAMPLE BASED ON THE COMPARISON OF FIRST-LINE BEVACIZUMAB + INTERFERON ALPHA-2A VS SUNITINIB IN RENAL CELL CARCINOMA (2009) (0)
- A population‐based cohort of adult patients with diabetes mellitus in a Western District of Austria: The Diabetes Landeck cohort (2022) (0)
- Predictors for temporary and permanent work disability in patients with Crohn's disease - results from a nationwide inflammatory bowel disease cohort study (2010) (0)
- SUN-PP229: The Role of Nutritional Status in the Association Between Grip Strength and Risk of Falling in the Old age: Results from the Kora-Age Study (2015) (0)
- OP140 Adult Patient Access To Electronic Health Records (2019) (0)
- COST-EFFECTIVENESS ANALYSIS ON STARTING PATIENTS WITH CHRONIC MYELOID LEUKEMIA ON A HIGHLY POTENT TYROSINE KINASE INHIBITOR AND EARLY SWITCHING TO IMATINIB. (2015) (0)
- Visualizing Methods For Discrete-Event-Simulations Using The Example Of A Breast Cancer Decision-Analytic Model. (2014) (0)
- HTA170 Including Decision-Analytic Benefit-Harm Evaluation in HTA - Different Age Ranges and Screening Intervals in Breast Cancer Screening in Germany (2022) (0)
- PIN34 INITIAL ANTIVIRAL TREATMENT OF CHRONIC HEPATITIS C:A GERMAN HEALTH TECHNOLOGY ASSESSMENT AND DECISION ANALYSIS (2002) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Uwe Siebert?
Uwe Siebert is affiliated with the following schools:
- University of Cape Town
- University of Cologne
- University of Alberta
- University of Hamburg
- University of Glasgow
- University of Toronto
- Tokyo Medical University
- Massachusetts General Hospital
- Yale University
- University of Minnesota
- University of Wisconsin–Madison
- London School of Hygiene and Tropical Medicine
- University of Bonn
- Harvard University
